Internal environment in cancer patients and proposal that carcinogenesis is adaptive response of glycolysis to overcome adverse internal conditions


In a series of our recent studies, stress was found to induce simultaneously hypothermia and hyperglycemia. These conditions are beneficial to obtain prompt force which depends on the glycolysis pathway and to escape emergency. Since we have noticed that such conditions resemble the internal environment seen in some cancer patients, it was investigated whe- ther such conditions were accompanied with other patients. We selected patients with early and advanced cancer. Body temperature and other parameters including blood gas contents were examined. A difference was seen in body temperature, namely, many patients showed hypothermia, irrespective of cancer stages. Fur- ther characterization of other parameters show- ed that hypothermia and hyperglycemia existed in many patients. They had immunosuppressive state and anemia. Blood gas analysis showed that oxygen contents were low and carbon dioxide contents were high in patients. These results suggest a possibility that the internal environment seen in patients is responsible to induce onset of disease and to maintain their cell growth, because cancer cells have an energy system of predominant glycolysis. Although hypothermia, hypoxia and hyperglycemia are important to activate the glycolysis pathway and to escape from emergency, such responses suppress the mitochondrial pathway for long span and may result in carcinogenesis.

Share and Cite:

Watanabe, M. , Miyajima, K. , Matsui, I. , Tomiyama-Miyaji, C. , Kainuma, E. , Inoue, M. , Matsumoto, H. , Kuwano, Y. and Abo, T. (2010) Internal environment in cancer patients and proposal that carcinogenesis is adaptive response of glycolysis to overcome adverse internal conditions. Health, 2, 781-788. doi: 10.4236/health.2010.27118.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Watanabe, M., Tomiyama-Miyaji, C., Kainuma, E., et al. (2008) Role of-adrenergic stimulus in stress-induced modulation of body temperature, blood glucose and innate immunity. Immunology Letters, 115(1), 43-49.
[2] Kainuma, E., Watanabe, M., Tomiyama-Miyaji, C., et al. (2009) Association of glucocorticoid with stress-induced modulation of body temperature, blood glucose and innate immunity. Psychoneuroendocrinology, 34(10), 1459- 1468.
[3] Kainuma, E., Watanabe, M., Tomiyama-Miyaji, C., et al. (2009) Proposal of alternative mechanism responsible for the function of high-speed swimsuits. Biomedical Research, 30(1), 69-70.
[4] Voet, D. and Voet, J.G. (2004) Glycolysis. In: D. Voet, J.G. Voet, Eds., Biochemistry, 3rd Edition, J. Wiley & Sons, New York, pp. 607-647.
[5] Dang, C.V. and Semenza, G.L. (1999) Oncogenic alterations of metabolism. Trends in Biochemical Science, 24(2), 68-72.
[6] Shaw, R.J. (2006) Glucose metabolism and cancer. Current Opinion in Cell Biology, 18(6), 598-608.
[7] Warburg, O. (1956) On the origin of cancer cells. Science, 123(3191), 309-314.
[8] Nijjar, T., Bassett, E., Garbe, J., et al. (2005) Accumulation and altered localization of telomere-associated protein TRF2 in immortally transformed and tumor-derived human breast cells. Oncogene, 24(20), 3369-3376.
[9] Rhiemeier, V., Breitenbach, U., Richter, K.H., et al. (2006) A novel aspartic proteinase-like gene expressed in stratified epithelia and squamous cell carcinoma of the skin. American Journal of Pathology, 168(4), 1354-1364.
[10] Arora, A., Kalra, N., Shukla, Y. (2006) Regulation of p21/ras protein expression by diallyl sulfide in DMBA induced neoplastic changes in mouse skin. Cancer Letters, 242(1), 28-36.
[11] Ikuta, S., Edamatsu, H., Li, M., Hu, L. and Kataoka, T. (2008) Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester. Cancer Research, 68(1), 64-72.
[12] Rountree, C.B., Senadheera, S., Mato, J.M., Crooks, G.M. and Lu, S.C. (2008) Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology, 47(4), 1288-1297.
[13] Koksal, Y., Caliskan, U. and Unal, E. (2009) Hypothermia in a child with Hodgkin disease. Journal of Pediatric Hematology Oncology, 31(2), 136-138.
[14] Nduka, C.C., Puttick, M., Coates, P., Yong, L., Peck, D. and Darzi, A. (2002) Intraperitoneal hypothermia during surgery enhances postoperative tumor growth. Surgical Endoscopy, 16(4), 611-615.
[15] Cortesi, E., Gascón, P., Henry, D., et al. (2005) Standard of care for cancer-related anemia: improving hemoglobin levels and quality of life. Oncology, 68(Suppl 1), 22-32.
[16] Heras, P., Argyriou, A.A., Papapetropoulos, S., Karagian- nis, S., Argyriou, K. and Mitsibounas, D. (2005) The impact of weekly dosing of epoetin alfa on the haematological parameters and on the quality of life of anemic cancer patients. European Journal of Cancer Care, 14(2), 108-112.
[17] Mock, V. and Olsen, M. (2003) Current management of fatigue and anemia in patients with cancer. Seminars in Oncology Nursing, 19(4 Suppl 2), 36-41.
[18] Fairclough, D.L., Gagnon, D.D., Zagari, M.J., Marschner, N. and Dicato, M. (2003) Evaluation of quality of life in a clinical trial with nonrandom dropout: The effect of epoetin alfa in anemic cancer patients. Quality of Life Research, 12(8), 1013-1027.
[19] Tchekmedyian, N.S. (2002) Anemia in cancer patients: significance, epidemiology, and current therapy. Oncology, 16(9 Suppl 10), 17-24.
[20] Ishiko, O., Sugawa, T., Tatsuta, I., et al. (1987) Anemia-inducing substance (AIS) in advanced cancer: inhibitory effect of AIS on the function of erythrocytes and immunocompetent cells. Japanese Journal of Cancer Research, 78(6), 596-606.
[21] Sagan, L. (1967) On the origin of mitosing cells. Journal of Theoretical Biology, 14(3), 255-274.
[22] Margulis, L. and Stolz, J.F. (1984) Cell symbiosis [correction of symbiosis] theory: status and implications for the fossil record. Advances in Space Research, 4(12), 195-201.
[23] Osinsky, S., Zavelevich, M. and Vaupel, P. (2009) Tumor hypoxia and malignant progression. Experimental Oncology, 31(2), 80-86.
[24] Denko, N.C. (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nature Reviews Cancer, 8(9), 705-713.
[25] Susnow, N., Zeng, L., Margineantu, D. and Hockenbery, D.M. (2009) Bcl-2 family proteins as regulators of oxidative stress. Seminars in Cancer Biology, 19(1), 42-49.
[26] Moreno-Sánchez, R., Rodríguez-Enríquez, S., Saavedra, E., Marín-Hernández, A. and Gallardo-Pérez, J.C. (2009) The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells? Biofactors, 35(2), 209-225.
[27] Vousden, K.H. and Ryan, K.M. (2009) P53 and metabolism. Nature Reviews Cancer, 9(10), 691-700.
[28] Abo, T. and Kawamura, T. (2002) Immunomodulation by the autonomic nervous system: Therapeutic approach for cancer, collagen diseases, and inflammatory bowel diseases. Therapeutic Apheresis, 6(5), 348-357.
[29] Sagiyama, K., Tsuchida, M., Kawamura, H., et al. (2004) Age-related bias in function of natural killer T cells and granulocytes after stress: Reciprocal association of steroid hormones and sympathetic nerves. Clinical and Experimental Immunology, 135(1), 56-63.
[30] Weinberg, R.A. (2007) The Biology of Cancer. 1st Edition, Garland Science, New York.
[31] Kondoh, H. (2008) Cellular life span and the Warburg effect. Experimental Cell Research, 314(9), 1923-1928.
[32] Nijsten, M.W.N. and van Dam, G.M. (2009) Hypothesis: Using the Warburg effect against cancer by reducing glucose and providing lactate. Medical Hypotheses, 73(1), 48-51.
[33] Heiden, M.G.V., Cantley, L.C. and Thompson, C.B. (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science, 324(5930), 1029-1033.
[34] Máximo, V., Lima, J., Soares, P. and Sobrinho-Sim?es, M. (2009) Mitochondria and cancer. Virchows Arch, 454(5), 481-495.
[35] Lee, H.-C. and Wei, Y.-H. (2009) Mitochondrial DNA instability and metabolic shift in human cancers. International Journal of Molecular Sciences, 10(2), 674-701.
[36] Gambhir, S.S. (2002) Molecular imaging of cancer with positron emission tomography. Nature Reviews Cancer, 2(9), 683-693.
[37] Vesselle, H., Schmidt, R.A., Pugsley, J.M., et al. (2000) Lung cancer proliferation correlates with [F-18] fluorodeoxyglucose uptake by positron emission tomography. Clinical Cancer Research, 6(10), 3837-3844.
[38] McEwen, B.S. (2000) Allostasis and allostatic load: Implications for neuropsychopharmacology. Neuropsychopharmacology, 22(2), 108-124.
[39] McEwen, B.S. (2004) Protection and damage from acute and chronic stress, allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Annals of the New York Academy of Sciences, 1032(1), 1-7.
[40] Sephton, S.E., Dhabhar, F.S., Keuroghlian, A.S., et al. (2009) Depression, cortisol, and suppressd cell-mediated immunity in metastatic breast cancer. Brain Behavior and Immunity, 23(8), 1148-1155.
[41] Du, J., Wang, Y., Hunter, R., et al. (2009) Dynamic regulation of mitochondrial function by glucocorticoids. Proceedings of the National Academy of Sciences of the United States of America, 106(9), 3543-3548.
[42] Bellingrath, S., Weigl, T. and Kudielka, B.M. (2009) Chronic work stress and exhaustion is associated with higher allostastic load in female school teachers. Stress, 12(1), 37-48.
[43] Alexander, J.L., Dennerstein, L., Woods, N.F., et al. (2007) Role of stressful life events and menopausal stage in wellbeing and health. Expert Review of Neurotherapeutics, 7(11 Suppl), 93-113.
[44] Tomiyama-Miyaji, C., Watanabe, M., Ohishi, T., et al. (2007) Modulation of the endocrine and immune systems by well-controlled hyperthermia equipment. Biomedical Research, 28(3), 119-125.
[45] Ohishi, T., Nukuzuma, C., Seki, A., et al. (2009) Alkalization of blood pH is responsible for survival of cancer patients by mild hyperthermia. Biomedical Research, 30(2), 95-100.
[46] Deberardinis, R.J., Sayed, N., Ditsworth, D., Thompson, C.B. (2008) Brick by brick: Metabolism and tumor cell growth. Current Opinion in Genetics and Development, 18(1), 54-61.
[47] Frezza, C. and Gottlieb, E. (2009) Mitochondria in cancer: not just innocent bystanders. Seminars in Cancer Biology, 19(1), 4-11.
[48] Gillies, R.J. and Gatenby, R.A. (2007) Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer and Metastasis Reviews, 26(2), 311-317.
[49] Fang, J.S., Gillies, R.D. and Gatenby, R.A. (2008) Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Seminars in Cancer Biology, 18(5), 330-337.
[50] Hu, M. and Polyak, K. (2008) Microenvironmental regulation of cancer development. Current Opinion in Genetics and Development, 18(1), 27-34.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.